A to Z subjects
Find stories by subject. Use the A-Z options to view other subjects.
C
- C. Difficile
- cabotegravir
- CagriSema (cagrilintide + semaglutide)
- Caliber Technologies
- Calquence
- Calquence (acalabrutinib)
- CAM2029
- Cambrex
- Cambridge University
- Camfil
- Campbell Bunce
- Canada Drug Agency (CDA-AMC)
- Cancer
- Cannabinoids
- Cannabis
- Capivasertib
- Caplyta (lumateperone)
- Capstan Therapeutics
- Capvaxive (pneumococcal polysaccharide conjugate vaccine (21-valent))
- carboplatin
- Cardiovascular disease
- cardiovascular disease (CVD)
- Carinne Brouillon
- Carlos Velez
- Caroline Peachey (European Pharmaceutical Review)
- Carrie Mason (Lonza)
- carvedilol
- Carvykti (ciltacabtagene autoleucel)
- Case Western Reserve University School of Medicine
- Casgevy
- Catalent
- Catalent Biologics
- Catherine Drew
- CD34+ cells (Protheracytes®).
- CDMO/CMO operations
- Cedrik Neike
- Celadon Pharmaceuticals
- Celea Therapeutics
- Céline Koelbert (Novartis)
- Cell and Gene Therapy Catapult
- Cell and Gene Therapy Catapult (CGTC)
- Cell culture automation
- Cellix
- CellProthera
- Celltrion
- Cellular Imaging & Analysis (CIA)
- Center for Biologics Evaluation and Research (CBER)
- Center for Drug Evaluation and Research (CDER)
- Centre for Process Innovation (CPI)
- Cerevel Therapeutics
- Cervical cancer
- Cervicorn Consulting
- cGMP
- ChAd3 Ebola Sudan vaccine
- Charité – Universitätsmedizin
- Charles Gore
- Charles River
- Charles River Laboratories
- Charles River Laboratories International
- chemotherapy
- Chemotherapy
- chemotherapy induced peripheral neuropathy (CIPN)
- Chia Tai Tianqing Pharmaceutical Group
- Chiara Celli (Institute of Biomedical Research Antoine Marxer)
- Chiesi
- Chiesi Farmaceutici SPA
- Chiesi Global Rare Diseases
- Chiesi Group
- Chiesi UK and Ireland
- Chikungunya virus
- Chip Baird
- Chitose Laboratory
- Cholesterol
- Chris Boerner
- Chris McDonald
- Christian Hauer
- Christian Schade
- Christiane Bardroff
- Christina Egelund
- Christina Gkousgkouni (Sanofi)
- Christine Caruso (Merck and Co)
- Christophe Bourdon
- Christophe Weber
- Christopher Austin
- Christopher Boerner
- Christopher Viehbacher
- Chromatography and separations
- chronic heart failure
- chronic kidney disease (CDK)
- chronic kidney disease (CKD)
- Chronic lung disease
- Chronic lymphocytic leukaemia (CLL)
- chronic obstructive pulmonary disease (COPD)
- chronic pain
- Chronic spontaneous urticaria (CSU)
- Ciltacabtagene autoleucel (cilta-cel)
- Cimzia (certolizumab pegol)
- Cindy Perettie
- Cipla
- Circularity in Primary Pharmaceutical Packaging Accelerator (CiPPPA)
- Claire D'Abreu Hayling
- Claire Lund
- Clare Blue
- Clarivate PLC
- Claude Bertrand
- Cleveland Clinic
- Clifford Chance
- Clifford Rossi (University of Maryland)
- Clinical Development
- Clinical Trials
- Clostridioides difficile
- CNX Therapeutics
- Cobenfy
- Cold Chain Supply
- Collategene
- Colorectal cancer
- Columvi
- Columvi (glofitamab)
- COMIRNATY®
- Committee for Medicinal Products for Human Use (CHMP)
- COMPASS Pathways
- Complicated urinary tract infections
- Conexxence (denosumab)
- Confederation of British Industry (CBI)
- Continuous manufacturing and PAT
- Contivue
- Contract Research Organisations (CROs)
- Controlled release and advanced delivery
- Corden Pharma
- Coronavirus
- Corticosteroids
- Council of Europe (EDQM)
- Courtney Soulsby (BSI)
- Courtney Wachtel (Charles River Laboratories)
- Courtney Wachtel (Charles River)
- Covid-19
- COVID-19 Vaccine Moderna
- CPHI
- CPhI
- CPHI Frankfurt
- CPTX2309
- Creyon Bio
- CRISPR Therapeutics
- Crohn's disease (CD)
- Cryoport
- Cryoport Systems
- CSL
- CSL Behring
- CSL Seqirus
- Cubrc
- CUTX-101
- cyclophosphamide
- Cystadrops
- Cystic Fibrosis
- Cytokine release syndrome (CRS)
- Cytokinetics
- cytomegalovirus (CMV)